Previous Section
Review Articles
41. Low-density lipoprotein reduction: is the risk worth the benefit?
- Author
- Sabharwal AK; Boord JB;
- Institution
- VA Tennessee Valley Geriatrics Research, Education, and Clinical Center, 1310 24th Avenue South, Nashville, TN 37212, USA.
- Journal
- Curr Atheroscler Rep. 2006 Jan;8(1):19-25.
- Abstract URL
- Click here to view abstract
42. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol.
- Author
- Harland JI; Haffner TA;
- Institution
- HarlandHall Associates, The Stables, Ranbury Ring, London Road, Poulton, Cirencester, Glos GL7 5HN, UK. jan.harland@harlandhall.co.uk
- Journal
- Atherosclerosis. 2008 Sep;200(1):13-27. Epub 2008 Apr 15.
- Abstract URL
- Click here to view abstract
43. Combination therapy in the management of mixed dyslipidaemia.
- Author
- Cannon CP;
- Institution
- Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. cpcannon@partners.org
- Journal
- J Intern Med. 2008 Apr;263(4):353-65.
- Abstract URL
- Click here to view abstract
44. Pharmacological therapies for raising HDL cholesterol beyond synthetic small molecules.
- Author
- Garcia RA;
- Institution
- University of California, San Diego, Department of Medicine, 9500 Gilman Dr, 0613J, BSB 2004, La Jolla, CA 92093, USA. r5garcia@ucsd.edu
- Journal
- Curr Opin Investig Drugs. 2008 Mar;9(3):274-80.
- Abstract URL
- Click here to view abstract
45. Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy.
- Author
- Hoenig MR; Rolfe BE; Campbell JH;
- Institution
- Royal Brisbane and Women's Hospital, Level 5 Pigeon Holes, Herton Road, Herston, Brisbane, Qld 4029, Australia. ebalk@tufts-nemc.org
- Journal
- Atherosclerosis. 2006 Feb;184(2):247-54. Epub 2005 Oct 7.
- Abstract URL
- Click here to view abstract
46. High-density lipoprotein cholesterol-raising strategies.
- Author
- Kuvin JT; Alsheikh-Ali AA; Karas RH;
- Institution
- Division of Cardiology, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine Boston, Massachusettes 0211, USA. jkuvin@tufts-nemc.org
- Journal
- J Cardiovasc Pharmacol. 2006 Feb;47(2):196-204.
- Abstract URL
- Click here to view abstract
47. Update on lipid-lowering therapy and LDL-cholesterol targets.
- Author
- Wiviott SD; Cannon CP;
- Institution
- TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. swiviott@partners.org
- Journal
- Nat Clin Pract Cardiovasc Med. 2006 Aug;3(8):424-36.
- Abstract URL
- Click here to view abstract
48. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines.
- Author
- Hennekens CH; Hollar D; Eidelman RS; Agatston AS;
- Institution
- Miller School of Medicine, University of Miami, Miami, Florida, USA. profchhmd@prodigy.net
- Journal
- MedGenMed. 2006 Feb 23;8(1):54.
- Abstract URL
- Click here to view abstract
49. The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases.
- Author
- Choi BG; Vilahur G; Yadegar D; Viles-Gonzalez JF; Badimon JJ;
- Institution
- Cardiovascular Biology Research Laboratory, Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
- Journal
- Curr Mol Med. 2006 Aug;6(5):571-87.
- Abstract URL
- Click here to view abstract
50. How safe is aggressive statin therapy?
- Author
- Guthrie RM;
- Institution
- The Ohio State University College of Medicine, Columbus, OH 43212, USA. guthrie.1@osu.edu
- Journal
- Prog Cardiovasc Nurs. 2006 Summer;21(3):140-5.
- Abstract URL
- Click here to view abstract
